🔴 Neurosense Therapeutics is trading 12.1% down

Neurosense Therapeutics is trading 12.1% lower at $4.20 on September 30, 2026; no company-specific catalyst was identified.

• Shares closed at $4.78 on September 29, after closing at $5.10 on September 28.
• The latest announcement was CFO Or Eisenberg’s participation in the September 29 ROTH Healthcare Opportunities Conference; this is not evidence of a direct cause.
• Supplied broad-market readings were positive or flat and do not explain the decline.